The LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete multiplex assay is intended for the rapid qualitative detection and differentiation of nucleic acid from the SARS-CoV-2, Influenza A, and/or Influenza B viruses in nasopharyngeal or anterior nasal swab from individuals suspected of COVID-19 and/or influenza by their healthcare provider
- Reliable and robust performance when compared to traditional RT-PCR tests.
- Direct amplification within 20 minutes drives lab’s efficiency and productivity.
Join the Fast Lab Network
For more information about LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete:
Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets.